Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays

British Journal of Cancer

Volumn 92, Issue 12, 2005, Pages 2249-2261

  De Wit, N J W ^a   Rijntjes, J ^a   Diepstra, J H S ^a   Van Kuppevelt, T H ^b   Weidle, U H ^c   Ruiter, D J ^a   Van Muijen, G N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Differential expression; Melanoma; Oligonucleotide array; Real time PCR; Tumour progression

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN NCK; BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 1; FATTY ACID BINDING PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; GROWTH FACTOR; HISTONE H2A; PROTEIN HR; PROTEIN MYADM; RAS PROTEIN; RAS PROTEIN RRAGD; THROMBOMODULIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; PROTEIN FOLDING; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MELANOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 22044454883     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602612     Document Type: Article

References (41)

1. Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, Fairlie DW, Breit SN, Paralkar VM, de Tribolet N, Van Meir EG, Hegi ME (2002) Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21: 4212-4219
2. Back SJ, Kim KS, Nixon JB, Wilson LC, Eling TE (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59: 901-908
3. Baldi A, Battista T, De Luca A, Santini D, Rossiello L, Baldi F, Natali PG, Lombardi D, Picardo M, Felsani A, Paggi MG (2003a) Identification of genes down-regulated during melanoma progression: a cDNA array study. Exp Dermatol 12: 213-218
4. Baldi A, Santini D, De Luca A, Paggi MG (2003b) cDNA array technology in melanoma: an overview. J Cell Physiol 196: 219-223
5. Becker B, Roesch A, Hafner C, Stolz W, Dugas M, Landthaler M, Vogt T (2004) Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting. J Invest Dermatol 122: 361-368
6. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94: 11514-11519
7. Brem R, Hildebrandt T, Jarsch M, van Muijen GN, Weidle UH (2001) Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line. Anticancer Res 21: 1731-1740
8. Brody JP, Williams BA, Wold BJ, Quake SR (2002) Significance and statistical errors in the analysis of DNA microarray data. Proc Natl Acad Sci USA 99: 12975-12978
9. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B, Breit SN (2003) MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 9: 2642-2650
10. Carr KM, Bittner M, Trent JM (2003) Gene-expression profiling in human cutaneous melanoma. Oncogene 22: 3076-3080
11. de Vries TJ, Verheijen JH, de Bart AC, Weidle UH, Ruiter DJ, van Muijen GN (1996) Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. Cancer Res 56: 1432-1439
12. de Wit NJ, Burtscher HJ, Weidle UH, Ruiter DJ, van Muijen GN (2002) Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays. Melanoma Res 12: 57-69
13. Dooley TP, Curto EV, Davis RL, Grammatico P, Robinson ES, Wilborn TW (2003) DNA microarrays and likelihood ratio bioinformatic methods: discovery of human melanocyte biomarkers. Pigment Cell Res 16: 245-253
14. Gomes LI, Silva RL, Stolf BS, Cristo EB, Hirata R, Soares FA, Reis LF, Neves EJ, Carvalho AF (2003) Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray. Anal Biochem 321: 244-251
15. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, Wu T, Niinobe M, Yoshikawa K, Hannigan GE, Halaban R (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282
16. Hosaka Y, Higuchi T, Tsumagari M, Ishii H (2000) Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Lett 161: 231-240
17. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L (1997) PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354: 40-44
18. Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, Batra SK (2003) Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 305: 598-604
19. Kerstens HM, Robben JC, Poddighe PJ, Melchers WJ, Boonstra H, de Wilde PC, Macville MV, Hanselaar AG (2000) AgarCyto: a novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix. J Histochem Cytochem 48: 709-718
20. Kim SJ, Shiba E, Ishii H, Inoue T, Taguchi T, Tanji Y, Kimoto Y, Izukura M, Takai S (1997) Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study. Anticancer Res 17: 2319-2323
21. Klur S, Toy K, Williams MP, Certa U (2004) Evaluation of procedures for amplification of small-size samples for hybridization on microarrays. Genomics 83: 508-517
22. Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC, Klamut HJ (2000) Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 275: 20127-20135
23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408
24. Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K, Diamandis EP (2003) Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer 88: 1101-1104
25. Nambiar S, Mirmohammadsadegh A, Bar A, Bardenheuer W, Roeder G, Hengge UR (2004) Applications of array technology: melanoma research and diagnosis. Expert Rev Mol Diagn 4: 549-557
26. Puskas LG, Zvara A, Hackler Jr L, Micsik T, van Hummelen P (2002) Production of bulk amounts of universal RNA for DNA microarrays. Biotechniques 33: 898-900, 902, 904
27. Rajeevan MS, Ranamukhaarachchi DG, Vernon SD, Unger ER (2001) Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 25: 443-451
28. Rihl M, Baeten D, Seta N, Gu J, De Keyser F, Veys EM, Kuipers JG, Zeidler H, Yu DT (2004) Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy. Ann Rheum Dis 63: 498-507
29. Rumpler G, Becker B, Hafner C, McClelland M, Stolz W, Landthaler M, Schmitt R, Bosserhoff A, Vogt T (2003) Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol 12: 761-771
30. Saghizadeh M, Brown DJ, Tajbakhsh J, Chen Z, Kenney MC, Farber DB, Nelson SF (2003) Evaluation of techniques using amplified nucleic acid probes for gene expression profiling. Biomol Eng 20: 97-106
31. Schneider J, Buness A, Huber W, Volz J, Kioschis P, Hafner M, Poustka A, Sultmann H (2004) Systematic analysis of T7 RNA polymerase based in vitro linear RNA amplification for use in microarray experiments. BMC Genomics 5: 29
32. Stirewalt DL, Pogosova-Agadjanyan EL, Khalid N, Hare DR, Ladne PA, Sala-Torra O, Zhao LP, Radich JP (2004) Single-stranded linear amplification protocol results in reproducible and reliable microarray data from nanogram amounts of starting RNA. Genomics 83: 321-331
33. Suehiro T, Shimada M, Matsumata T, Taketomi A, Yamamoto K, Sugimachi K (1995) Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma. Hepatology 21: 1285-1290
34. Tabata M, Sugihara K, Yonezawa S, Yamashita S, Maruyama I (1997) An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential. J Oral Pathol Med 26: 258-264
35. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson Jr HF, Hampton GM (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61: 5974-5978
36. Westphal JR, van't-Hullenaar RG, van-der-Laak JA, Cornelissen IM, Schalkwijk LJ, van-Muijen GN, Wesseling P, de-Wilde PC, Ruiter DJ, de-Waal RM (1997) Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer 76: 561-570
37. Wilhelm S, Schmitt M, Parkinson J, Kuhn W, Graeff H, Wilhelm OG (1998) Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc. Int J Oncol 13: 645-651
38. Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49
39. Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT (2003) Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2: 1023-1029
40. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res 30: e48
41. Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, Nakagawa K, Klevesath M, Wilhelm S, Bohrer H, Nakagawa M, Graeff H, Martin E, Stern DM, Rosenberg RD, Ziegler R, Nawroth PP (1998) Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest 101: 1301-1309